What are our options for children with severe asthma?
This webinar has been initiated and commissioned by Boehringer Ingelheim Limited and organised in partnership with Guidelines in Practice. Boehringer Ingelheim Limited has reviewed the scope of the webinar, commissioned the speaker, and approved all materials related to the webinar. The speaker has been paid an honorarium. The views and ...
The appropriate use of inhaled corticosteroids (ICS) in COPD
This webinar has been initiated and commissioned by Boehringer Ingelheim Limited and organised in partnership with Guidelines in Practice. Boehringer Ingelheim Limited has reviewed the scope of the webinar, commissioned the speaker, and approved all materials related to the webinar. The speaker has been paid an honorarium. The views and ...
Real-world evidence in the management of type 2 diabetes: switching from other DPP‑4 inhibitors to alogliptin (Vipidia®)
This promotional educational webinar has been organised and funded by Takeda UK Ltd. See bottom of page for full disclaimer.
Secondary event prevention and risk stratification in patients with symptomatic peripheral arterial disease (PAD)
Information intended for healthcare professionals only. The development of this Guidelines in Practice video has been commissioned by Bayer plc. Please see the bottom of the page for full disclaimer.
Secondary event prevention and risk stratification in patients with stable coronary artery disease (CAD)
Information intended for healthcare professionals only. The development of this Guidelines in Practice video has been commissioned by Bayer plc. Please see the bottom of the page for full disclaimer.
Implementing the clinical guideline on pancreatic exocrine insufficiency in diabetes
Information intended for healthcare professionals only. Guidelines in Practice approached Mylan for an educational grant to support the production of an implementation checklist. Please see the bottom of the page for the full disclaimer.
Implementing the Primary Care Dermatology Society guideline and primary care treatment pathway for actinic (solar) keratosis
Information intended for healthcare professionals only. Guidelines in Practice approached Almirall Ltd for an educational grant to support the production of an implementation checklist. Please see the bottom of the page for full disclaimer.
Switching appropriate patients with type 2 diabetes to alogliptin from existing DPP-4 inhibitors: experience and outcomes from three Clinical Commissioning Groups and Local Health Boards
Choosing a dipeptidyl peptidase-4 inhibitor in adults with type 2 diabetes and co‑morbidities
How should inhaled steroids be used in the management of asthma in adults within a primary care setting?
The re-usable Respimat® Soft Mist™ inhaler
Managing common skin conditions without antibiotics
Guideline for the managed introduction of biosimilar basal insulin
Respimat® Soft Mist™ reusable inhaler: patient benefits and environmental impact
This animation has been commissioned and funded by Boehringer Ingelheim Ltd and developed in partnership with Guidelines in Practice. Boehringer Ingelheim Ltd suggested the topic and the presenter, and carried out full medical approval on all materials to ensure compliance with regulations. The sponsorship fee included an honorarium for the ...
Fencino® (fentanyl transdermal patch): clinical and practical considerations
This animation has been commissioned and funded by Ethypharm UK Ltd and developed in partnership with Guidelines in Practice. Ethypharm UK Ltd suggested the topic and the presenter, and carried out full medical approval on all materials to ensure compliance with regulations. The sponsorship fee included an honorarium for the ...
Amgevita® ▼ (adalimumab biosimilar)
This formulary discussion guide was developed from content provided by Amgen Ltd in a format developed by Guidelines in Practice.
PROSTAP® DCS (leuprorelin acetate)
This formulary decision guide was developed by Guidelines in Practice based on content and funding provided by Takeda UK Ltd.
Doublebase Dayleve™ Gel (isopropyl myristate, liquid paraffin)
Information intended for healthcare professionals only.
Cost-benefit of prescribing emollients for eczema patients
The content of this infographic has been developed by Johnson & Johnson Ltd.